Change search criteria ↓

Search results

1 384 projects found matching your search criteria:

  1. 401. Assessment of virulence, biofilm formation and drug-susceptibility of Candida albicans treated with plant essential oils…

    Principal investigator: Aleksandra Budzyńska

    Uniwersytet Łódzki, Wydział Biologii i Ochrony Środowiska

    Call: PRELUDIUM 1, Panel: NZ6

  2. 402. The analysis of tolerogenic properties of T regulatory cells in organ transplants as potential therapy diminishing the r…

    Principal investigator: prof. Piotr Trzonkowski

    Gdański Uniwersytet Medyczny, Wydział Lekarski z Oddziałem Stomatologicznym

    Call: OPUS 1, Panel: NZ6

  3. 403. Anticancer activity of the thiosemicarbazone derivatives

    Principal investigator: dr Anna Dominika Mrozek-Wilczkiewicz

    UNIWERSYTET ŚLĄSKI, Wydział Matematyki, Fizyki i Chemii

    Call: SONATA 7, Panel: NZ7

  4. 404. CTC-on-CAM: a platform for studying heterogeneity, epithelial-mesenchymal transition, and therapeutic sensitivity of cir…

    Principal investigator: prof. Marek Arkadiusz Murias

    Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu

    Call: OPUS 29, Panel: NZ7

  5. 405. MIST: Artificial intelligence-assisted design of experiments as a tool to streamline the development of siRNA-lipid nano…

    Principal investigator: dr hab. Paulina Krystyna Skupin-Mrugalska

    Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu

    Call: OPUS 29, Panel: NZ7

  6. 406. Natural and synthetic isothiocyanates as a compounds with potential anticancer activity

    Principal investigator: Mateusz Psurski

    Politechnika Wrocławska, Wydział Chemiczny

    Call: PRELUDIUM 1, Panel: NZ4

  7. 407. Light Against Darkness: Biocompatible Photoactivated Pharmaceuticals for Combating Multidrug Resistant Bacterial Infecti…

    Principal investigator: dr hab. Janusz Marcin Dąbrowski

    Uniwersytet Jagielloński

    Call: OPUS 28, Panel: NZ7

  8. 408. Towards a functional cure of HIV infection.

    Principal investigator: dr Anna Kula-Pacurar

    Uniwersytet Jagielloński

    Call: WEAVE-UNISONO, Panel: NZ6

  9. 409. Medical Aid-in-Dying – A Revision of the Dominant Classifications

    Principal investigator: dr hab. Tomasz Żuradzki

    Uniwersytet Jagielloński, Wydział Filozoficzny

    Call: PRELUDIUM BIS 3, Panel: HS1

  10. 410. A new approach of vision restoration based on modified Rabies virus tracing technique

    Principal investigator: dr hab. Andrzej Tomasz Foik

    Instytut Chemii Fizycznej Polskiej Akademii Nauk

    Call: SONATA BIS 9, Panel: NZ5

  11. 411. New, multifunctional nanoparticles for combined photothermal and gene silencing cancer therapy

    Principal investigator: prof. Stefan Jurga

    Uniwersytet im. Adama Mickiewicza w Poznaniu, Centrum Nanobiomedyczne

    Call: OPUS 11, Panel: ST8

  12. 412. The study of mechanisms that enhance the antitumor activity of 5-FU by the use of vitamin D analogs in human colon cance…

    Principal investigator: dr Magdalena Milczarek

    Instytut Immunologii i Terapii Doświadczalnej im. Ludwika Hirszfelda Polskiej Akademii Nauk

    Call: PRELUDIUM 3, Panel: NZ5

  13. 413. TP53 mutations drive alternative FGFR1 splicing - the study of consequences for cancer progression and therapeutic oppor…

    Principal investigator: Weronika Wojtyś

    Instytut Medycyny Doświadczalnej i Klinicznej im. Mirosława Mossakowskiego PAN

    Call: PRELUDIUM 24, Panel: NZ4

  14. 414. Molecular and cellular landscape of pulmonary and hepatic metastases of colorectal cancer with potential clinical implic…

    Principal investigator: dr Marta Aleksandra Popęda

    Gdański Uniwersytet Medyczny, Wydział Lekarski

    Call: PRELUDIUM 20, Panel: NZ4

  15. 415. Psychedelics as Therapeutic Candidates in Neurodegenerative Disorders Treatment– a Study in Spinocerebellar Ataxia Type …

    Principal investigator: dr Urszula Joanna Kozłowska

    Instytut Chemii Bioorganicznej PAN

    Call: SONATINA 5, Panel: NZ4

  16. 416. The role of epigenetic readers from BET family in the emergence and treatment of schizophrenia-like abnormalities in a n…

    Principal investigator: prof. Marzena Małgorzata Maćkowiak

    Instytut Farmakologii PAN

    Call: OPUS 16, Panel: NZ4

  17. 417. Studies on the biological activity of selected aminomethylidenebisphosphonic acids

    Principal investigator: dr Anna Nasulewicz-Goldeman

    Instytut Immunologii i Terapii Doświadczalnej im. Ludwika Hirszfelda Polskiej Akademii Nauk

    Call: OPUS 7, Panel: NZ4

  18. 418. Identification of the crucial metabolic pathways in the central nervous system in the patophysiology of opioid dependenc…

    Principal investigator: dr hab. Piotr Suder

    Akademia Górniczo-Hutnicza im. Stanisława Staszica w Krakowie, Wydział Inżynierii Materiałowej i Ceramiki

    Call: OPUS 4, Panel: NZ4

  19. 419. Inhibition of melanoma metastasis afrer proton beam treatment

    Principal investigator: prof. Krystyna A. Urbańska

    Uniwersytet Jagielloński, Wydział Biochemii, Biofizyki i Biotechnologii

    Call: OPUS 4, Panel: NZ4

  20. 420. The effect of enriched environment on the epigenetic mechanism in neurodevelopmental model of schizophrenia.

    Principal investigator: dr Ewelina Bator

    Instytut Farmakologii PAN

    Call: PRELUDIUM 4, Panel: NZ4

  21. 421. Studies on the application of the olfactory ensheathing cells in the treatment of complete spinal cord injuries in human…

    Principal investigator: dr Wojciech Fortuna

    Uniwersytet Medyczny im. Piastów Śląskich we Wrocławiu, Wydział Farmaceutyczny z Oddziałem Analiutyki Medycznej, Wydział Lekarski Kształcenia Podyplomowego

    Call: HARMONIA 3, Panel: NZ4

  22. 422. PIM kinases as rational therapeutic targets in lymphoid malignancies.

    Principal investigator: dr hab. Przemysław Juszczyński

    Instytut Hematologii i Transfuzjologii

    Call: OPUS 2, Panel: NZ4

  23. 423. Novel model for in vitro analyzing breast cancer, colorectal cancer and prostate cancer cells.

    Principal investigator: prof. Piotr Rieske

    Uniwersytet Medyczny w Łodzi, Wydział Lekarski

    Call: OPUS 1, Panel: NZ4

  24. 424. Contribution of nitrergic transmission in the modulation of L-dopa activity in the rat 6-OHDA model of Parkinson's disea…

    Principal investigator: dr hab. Elżbieta Kazimiera Lorenc-Koci

    Instytut Farmakologii PAN

    Call: OPUS 1, Panel: NZ4

  25. 425. Nanostructured lipid systems with Cannabis sativa L. extracts in the regulation of skin aging processes and microbiome b…

    Principal investigator: dr Aleksandra Bernadeta Zielińska

    Instytut Włókien Naturalnych i Roślin Zielarskich

    Call: OPUS 29, Panel: ST11

  26. 426. FHOD1 as a Regulator of Lipid Droplet–Mitochondria Interactions: A New Dimension of Metabolic Control in Skin Melanoma C…

    Principal investigator: dr hab. Antonina Joanna Mazur

    Uniwersytet Wrocławski

    Call: OPUS 29, Panel: NZ3

  27. 427. Dual-Target Compounds Modulating EAAT2 and Kv7.2/3 Channels: A Rational Strategy Toward Novel Antiseizure and Antinocice…

    Principal investigator: dr Michał Andrzej Abram

    Uniwersytet Jagielloński

    Call: OPUS 29, Panel: NZ7

  28. 428. The JAK/STAT pathway as a molecular contributor to the development of endometriosis: therapeutic potential of JAK inhibi…

    Principal investigator: Aleksander Radosław Rycerz

    Uniwersytet Medyczny w Łodzi

    Call: PRELUDIUM 24, Panel: NZ7

  29. 429. Mini-tumors, big answers: Modeling of immune system's activation with organoid-based PDT-on-Chip technology

    Principal investigator: Marta Karolina Warszyńska

    Uniwersytet Jagielloński

    Call: PRELUDIUM 24, Panel: NZ7

  30. 430. Mind the gap! Plasmonic nanocavity for spectroscopic trapping of local molecularrearrangements in DNA upon epigenetic mo…

    Principal investigator: prof. Ewelina Wioletta Lipiec

    Uniwersytet Jagielloński

    Call: OPUS 28, Panel: ST4

  31. 431. An innovative approach to the elimination of cancer cells in disseminated ovarian cancer in various preclinical models b…

    Principal investigator: dr hab. Joanna Ewa Jazowiecka-Rakus

    Kardio-Med Silesia Sp. z o.o.

    Call: OPUS 28, Panel: NZ5

  32. 432. Ir(III), Re(I) and Heterobimetallic Ir(III)–Re(I) Systems as Effective Emitters and Photosensitizers

    Principal investigator: dr Katarzyna Anna Choroba

    UNIWERSYTET ŚLĄSKI

    Call: SONATA 20, Panel: ST4

  33. 433. Investigation of the mechanism of enhanced liposome delivery to tumors and its application for dual target immunotherapy

    Principal investigator: dr hab. Tomasz Piotr Rygiel

    Instytut Medycyny Doświadczalnej i Klinicznej im. Mirosława Mossakowskiego PAN

    Call: OPUS 28, Panel: NZ7

  34. 434. Prevalence of viral genomes, histological, and immunohistochemical features of myocarditis in the myocardium, and freque…

    Principal investigator: dr hab. Krzysztof Ozierański

    Warszawski Uniwersytet Medyczny

    Call: SONATA 20, Panel: NZ6

  35. 435. Non-canonical Estrogen Receptor (ER) signalling in breast cancer progression

    Principal investigator: prof. Rafał Sebastian Sądej

    Gdański Uniwersytet Medyczny

    Call: OPUS 28, Panel: NZ3

  36. 436. Application of bioconjugation strategy to the synthesis of anticancer Trojan horses

    Principal investigator: dr hab. Michał Piotr Antoszczak

    Uniwersytet im. Adama Mickiewicza w Poznaniu

    Call: OPUS 28, Panel: ST5

  37. 437. Computational and experimental nanodosimetry for proton radiotherapy

    Principal investigator: dr hab. Antoni Wojciech Ruciński

    Instytut Fizyki Jądrowej im. Henryka Niewodniczańskiego PAN

    Call: WEAVE-UNISONO, Panel: ST2

  38. 438. Exploring DMRTA2 in Glioblastoma: Epigenetic Regulation, Angiogenesis Disruption, and Biomarker Development

    Principal investigator: dr Marta Magdalena Maleszewska-Bobińska

    Uniwersytet Warszawski

    Call: SONATA BIS 14, Panel: NZ3

  39. 439. Quad-TNT: Quadruplex-Targeted Photo-Therapy for Triple-Negative Tumors

    Principal investigator: dr Marco Deiana

    Politechnika Wrocławska

    Call: SONATA BIS 14, Panel: NZ5

  40. 440. Phage-Antimicrobial combination Strategies for management of multidrug-resistant E. coli and K. pneumoniae

    Principal investigator: prof. Krystyna Dąbrowska

    Instytut Immunologii i Terapii Doświadczalnej im. Ludwika Hirszfelda Polskiej Akademii Nauk

    Call: JPIAMR ACTION Call 2024, Panel: NZ7

  41. 441. The use of photosensitizers to improve the efficiency of radiotherapy

    Principal investigator: dr Justyna Anna Czapla

    Centrum Onkologii - Instytut im. Marii Skłodowskiej-Curie

    Call: OPUS 27, Panel: NZ5

  42. 442. Assessment of long-term effects of semaglutide administered in repeated short cycles in obese mice

    Principal investigator: dr hab. Jakub Łukasz Wojcieszak

    Uniwersytet Medyczny w Łodzi

    Call: OPUS 27, Panel: NZ7

  43. 443. Evaluation of the relationship between doxorubicin resistance, epithelial-mesenchymal plasticity, and effects of selecte…

    Principal investigator: Dominika Kunachowicz

    Uniwersytet Medyczny im. Piastów Śląskich we Wrocławiu, Wydział Farmaceutyczny z Oddziałem Analiutyki Medycznej

    Call: PRELUDIUM 23, Panel: NZ5

  44. 444. REMIND HF - Evaluation of REmote Motivational INterviewing for Disease management in Heart Failure patients and their ca…

    Principal investigator: prof. Izabella Uchmanowicz

    Uniwersytet Medyczny im. Piastów Śląskich we Wrocławiu, Wydział Farmaceutyczny z Oddziałem Analiutyki Medycznej

    Call: OPUS 27, Panel: NZ7

  45. 445. Organometallic marriage of sugars with porphyrins. Towards new photosensitizers.

    Principal investigator: dr Maciej Malinowski

    Politechnika Warszawska, Wydział Chemiczny

    Call: SONATA 19, Panel: ST5

  46. 446. ROS-Scavenging Magnetic Nanozymes with Remote Activation for Alzheimer Disease

    Principal investigator: dr hab. Anna Ludwika Haduch

    Instytut Farmakologii PAN

    Call: M-ERA.NET 3 Call 2023, Panel: NZ5

  47. 447. Targeting enzymes of the parasite's purine salvage pathway as a new approach to combat H. pylori infections, including t…

    Principal investigator: prof. Maria Agnieszka Bzowska

    Uniwersytet Warszawski, Wydział Fizyki

    Call: OPUS 26, Panel: NZ1

  48. 448. Modulation of protein interaction networks as a new therapeutic target in the treatment of hereditary retinal dystrophie…

    Principal investigator: dr Xiaonan Liu

    Śląski Uniwersytet Medyczny w Katowicach, Wydział Nauk Medycznych w Katowicach

    Call: SONATA 19, Panel: NZ5

  49. 449. Integrated multi-omics approach to accelerate anticancer drug discovery by targeting metabolic reprogramming in human co…

    Principal investigator: dr hab. Danuta Dudzik

    Gdański Uniwersytet Medyczny, Wydział Farmaceutyczny

    Call: OPUS 26, Panel: NZ7

  50. 450. Application of superparamagnetic iron oxide nanoparticles (SPION) in inhaled theranostic systems containing antifungal d…

    Principal investigator: dr Gabriela Małgorzata Wyszogrodzka-Gaweł

    Uniwersytet Jagielloński, Collegium Medicum

    Call: SONATA 19, Panel: NZ7

Graphic design and implementation: Jakub Piotrowski